Safety Study of Nebulized RNS60 to Treat Asthma.

NCT01057498 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: RNS60
DRUG: RNS60 - single dose

Sponsor

Revalesio Corporation